Canopy CEO: We'll 'Disrupt the Heck' Out of Pharma
*By Carlo Versano*
At the end of a week that saw the nascent cannabis sector soar to record valuations (with enough [volatility](https://cheddar.com/videos/making-sense-of-tilrays-stock-chart) to make your head spin), at least one exec isn't getting high off his own supply.
Bruce Linton, CEO of Canopy Growth ($CGC), told Cheddar Friday that he is focused on using a recent $4 billion cash injection from Constellation Brands to accelerate his business operations as new markets open up for legal marijuana use.
The market for legal pot went from a handful of countries like Canada, where Canopy is based, to now over 30 globally, Linton said in an interview, and Constellation's stake "is the kind of rocket fuel we need."
As speculators send the stocks higher ー Canopy is up 100 percent since the August deal, while Tilray ($TLRY) is up 1,000 percent since its July IPO ー Linton is keeping his nose to the grindstone developing new uses for cannabis, illustrated by the 39 patents Canopy filed in the last year just for sleep-related cannabinoid products. He sees other uses as well, from anxiety to sports recovery, which begs the question: is Canopy a pharma company?
"We're going to have enough intellectual property and activity that it would be difficult for pharma companies...not to need to play with us," Linton said. "We're going to disrupt the heck out of them."
Speaking of disruption, Linton said he wasn't bothered by parallels with the dot-com bubble of the early 2000s. He said Canopy had more in common with a Google or Amazon ー established businesses with strong fundamentals ー than any of the internet stocks that were relegated to the tech boneyard after the bubble popped.
But for an industry like cannabis that is entirely dependent on regulation, there will always be a risk, Linton noted. For every country like Canada, which legalized medical marijuana in 2001 and will allow recreational use starting October 17, there's an Italy ー where medical marijuana is legal but heavily restricted ー or a Japan ー where it is strictly outlawed. Put another way, Canopy may have the best legal pot cultivation and distribution in the world, but its long-term success on a global scale may be capped by shifting regulatory and political climates.
Still, Linton sees the writing on the wall in places like South America, Australia, and the EU. As regulatory barriers come down, he said Canopy's strong production operations will lead the market.
"People can fight for who's going to be the second best," Linton said. "We're going to be the best and the largest and the most dominant on the planet over the next decade."
For full interview [click here](https://cheddar.com/videos/canopy-growth-blazing-a-trail).
Solid-state battery maker Factorial Energy recently raised $200 million in a Series D round led by Mercedes-Benz and Stellantis. Factorial says the funding will be used to accelerate commercial production and deployment of its solid-state battery technology, which the company says is safer, and offers up to 50% more driving range than current lithium-ion technology. Factorial also has joint development agreements (announced in late 2021) with Mercedes-Benz, Stellantis, and Hyundai, three of the top 10 global automotive manufacturers, to commercialize its batteries. Factorial CEO Siyu Huang joined Cheddar News' Closing Bell to discuss.
Art Hogan, Chief Market Strategist at National Securities, joins Cheddar News' Closing Bell, where he says investors are paying more attention to earnings this week, which is leading to the Dow, S&P, and Nasdaq gaining this week. Hogan also breaks down Spotify and Meta's earnings, both of which came out after the bell.
Google's parent company Alphabet reported blockbuster fourth quarter earnings, boosted by better-than-expected Google ad revenue and Google Cloud revenue. The results sent Alphabet's stock soaring, and the company could come close to hitting a $2 trillion market valuation similar to other tech giants Apple and Microsoft. The company also announced a 20-for-1 stock split, which would make shares more accessible to would-be investors. Mark Lehmann, CEO at JMP Securities, a Citizens Company, joins Closing Bell to discuss Alphabet's earnings report, whether the company will reach a $2 trillion market cap, its stock split, and more.
Kendra Bracken-Ferguson, founder of BrainTrust Founders Studio joins Cheddar News to talk about the importance of supporting Black beauty and wellness founders.
Damali Peterman, founder and CEO of Breakthrough ADR, joins Cheddar News to discuss what Black professionals are up against in the workplace this year.
Rep. Nancy Mace (R-S.C. 1st District) joined Cheddar to discuss her cannabis legalization bill, the States Reform Act, and the prospects for gaining bipartisan support for a bill that has garnered the endorsement of e-commerce giant Amazon. This legislation is supported by businesses large and small, Amazon obviously being the most recent and largest business to support it," Mace said. "They don't want to sell pot. But what it does do is it affects their working employment pool." She stated that 10 percent of eligible new hires for Amazon are affected by restrictive marijuana laws. The representative also explained that the bill leaves equity provisions up to the states rather than mandating them on a federal level.
Jess Hunichen and Emily Ward, co-founder of Shine Talent Group join Cheddar News to talk about The BodCon conference and how it empowers men and women to feel confident.
